medicineのメーカーや取扱い企業、製品情報、参考価格、ランキングをまとめています。
イプロスは、 製造業 ・ BtoB における情報を集めた国内最大級の技術データベースサイトです。

medicine - メーカー・企業32社の製品一覧とランキング

更新日： 集計期間:Oct 01, 2025～Oct 28, 2025
※当サイトの各ページの閲覧回数を元に算出したランキングです。

medicineのメーカー・企業ランキング

更新日： 集計期間:Oct 01, 2025～Oct 28, 2025
※当サイトの各ページの閲覧回数を元に算出したランキングです。

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. スペラファーマ Osaka//others
  3. null/null
  4. 4 立山化成 Toyama//Manufacturing and processing contract
  5. 5 関東化学株式会社 バイオケミカル部 Tokyo//Chemical
企業ランキングへ

medicineの製品ランキング

更新日： 集計期間:Oct 01, 2025～Oct 28, 2025
※当サイトの各ページの閲覧回数を元に算出したランキングです。

  1. Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.
  2. For various titrations! The titration "indicator" specified in JIS K8001. 関東化学株式会社 バイオケミカル部
  3. Tateyama Kasei Co., Ltd. Kyushu Factory 立山化成
  4. Cavity prevention medicine Gurupepr カツマタ 医薬品製造販売部
  5. 4 [Research Material] The Global Market for Neglected Tropical Disease (NTD) Treatments マーケットリサーチセンター

medicineの製品一覧

376～390 件を表示 ／ 全 590 件

表示件数
[Research Material] Global Market for Amantadine Hydrochloride Oral Medication

[Research Material] Global Market for Amantadine Hydrochloride Oral Medication

Global Market for Amantadine Hydrochloride Oral Medications: Tablets, Capsules, Syrups, Parkinson's Disease, Influenza

This research report (Global Amantadine HCl Oral Market) investigates and analyzes the current status and outlook for the global market of amantadine hydrochloride oral medications over the next five years. It includes information on the overview of the global amantadine hydrochloride oral medication market, trends of key companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include tablets, capsules, and syrup, while the segments by application focus on Parkinson's disease and influenza. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of amantadine hydrochloride oral medications. It also includes the market share of major companies in the amantadine hydrochloride oral medication sector, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Zika Virus Infection Treatment Drugs

[Research Material] Global Market for Zika Virus Infection Treatment Drugs

Global Market for Zika Virus Infection Treatments: Oral Medications, Injectable Medications, Hospitals, Home Healthcare, Clinics, Others

This research report (Global Zika Virus Infection Drug Market) investigates and analyzes the current status and outlook for the global market for Zika virus infection treatments over the next five years. It includes information on the overview of the global Zika virus infection treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include oral medications and injectables, while the segments by application cover hospitals, home healthcare, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Zika virus infection treatments. It also includes the market share of major companies in the Zika virus infection treatment sector, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Terbinafine Hydrochloride Medication

[Research Material] Global Market for Terbinafine Hydrochloride Medication

World Market for Terbinafine Hydrochloride: Topical, Oral, Nail Infections, Toenail Infections, Others

This research report (Global Terbinafine Hydrochloride Drug Market) investigates and analyzes the current status and outlook for the global terbinafine hydrochloride drug market over the next five years. It includes information on the overview of the global terbinafine hydrochloride drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on topical and oral forms, while the segments by application target nail infections, toenail infections, and others. The regional segments calculate the market size of terbinafine hydrochloride drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the terbinafine hydrochloride drug market, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Gene Therapy Medicine

[Research Material] The Global Market for Gene Therapy Medicine

World Market for Gene Therapy Medicine: Oral, Injection, Cancer, Monogenic, Infectious Diseases, Cardiovascular Diseases, Others

This research report (Global Gene Therapy Medicine Market) investigates and analyzes the current state and future outlook of the global gene therapy medicine market over the next five years. It includes information on the overview of the global gene therapy medicine market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on oral and injection methods, while the segments by application target cancer, monogenic diseases, infectious diseases, cardiovascular diseases, and others. The regional segments calculate the market size of gene therapy medicine by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in gene therapy medicine, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Treatment of Progressive Ataxia and Muscle Weakness

[Research Material] The Global Market for Treatment of Progressive Ataxia and Muscle Weakness

Global Market for Treatment of Progressive Ataxia and Muscle Weakness: Monoclonal Antibodies, Small Molecule Technology, Friedreich's Ataxia, Hereditary Neuropathies ...

This research report (Global Treatment for Syndromes of Progressive Ataxia and Weakness Disorders Market) investigates and analyzes the current status and outlook for the global market for the treatment of progressive ataxia and weakness disorders over the next five years. It includes information on the overview of the global market for the treatment of progressive ataxia and weakness disorders, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on monoclonal antibodies and small molecule technology, while the segments by application target Friedreich's ataxia, hereditary neuropathy, Machado-Joseph disease, progressive bulbar palsy, multiple sclerosis, and others. The regional segments calculate the market size for the treatment of progressive ataxia and weakness disorders by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Document] Global Market for Composite Calamine Lotion

[Research Document] Global Market for Composite Calamine Lotion

Global Market for Compound Calamine Lotion: 50ml, 100ml, Urticaria, Eczema, Others

This research report (Global Compound Calamine Lotion Market) investigates and analyzes the current status and outlook for the global market of compound calamine lotion over the next five years. It includes information on the overview of the global compound calamine lotion market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on 50ml and 100ml, while the segments by application target urticaria, eczema, and others. The regional segments calculate the market size of compound calamine lotion by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the compound calamine lotion sector, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Plasma-Derived Therapies

[Research Material] Global Market for Plasma-Derived Therapies

World Market for Plasma-Derived Therapies: Albumin, Immunoglobulin, Factor VIII, Others, Hemophilia, Primary Immunodeficiency (PID), Idiopathic Blood ...

This research report (Global Plasma-derived Therapies Market) investigates and analyzes the current status and outlook for the global plasma-derived therapies market over the next five years. It includes information on the overview of the global plasma-derived therapies market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the plasma-derived therapies market include albumin, immunoglobulin, factor VIII, and others, while the segments by application cover hemophilia, primary immunodeficiency (PID), idiopathic thrombocytopenic purpura (ITP), COVID-19, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for plasma-derived therapies. The report also includes the market share of major companies in plasma-derived therapies, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Head and Neck Cancer Treatment Drugs/Treatments

[Research Material] Global Market for Head and Neck Cancer Treatment Drugs/Treatments

Head and neck cancer treatment drugs/treatment global market: PD inhibitors, microtubule inhibitors, EGFR inhibitors, surgery, radiation therapy, chemotherapy, immunotherapy.

This research report (Global Head and Neck Cancer Drugs/Therapeutics Market) investigates and analyzes the current status and outlook for the global market of head and neck cancer treatment drugs/therapeutics over the next five years. It includes information on the overview of the global head and neck cancer treatment drugs/therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the head and neck cancer treatment drugs/therapeutics market focus on PD inhibitors, microtubule inhibitors, and EGFR inhibitors, while the segments by application target surgery, radiation therapy, chemotherapy, and immunotherapy. The regional segments calculate the market size for head and neck cancer treatment drugs/therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the head and neck cancer treatment drugs/therapeutics market, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Amlodipine Besylate

[Research Material] Global Market for Amlodipine Besylate

World Market for Amlodipine Besylate: 2.5mg, 5mg, 10mg, Hypertension, Heart Disease

This research report (Global Amlodipine Besylate Market) investigates and analyzes the current state and outlook for the global market of amlodipine besylate over the next five years. It includes information on the overview of the global amlodipine besylate market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the amlodipine besylate market focus on 2.5mg, 5mg, and 10mg, while the segments by application target hypertension and heart disease. The regional segments calculate the market size of amlodipine besylate by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the amlodipine besylate market, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Gout Treatment Drugs

[Research Material] Global Market for Gout Treatment Drugs

World Market for Gout Treatment Drugs: NSAIDs, Corticosteroids, Colchicine, Uric Acid Lowering Drugs, Acute Gout, Chronic Gout

This research report (Global Gout Therapeutics Market) investigates and analyzes the current status and outlook for the global market for gout therapeutics over the next five years. It includes information on the overview of the global gout therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include NSAIDs, corticosteroids, colchicine, and urate-lowering drugs, while the segments by application focus on acute gout and chronic gout. The regional segments calculate the market size for gout therapeutics by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in gout therapeutics, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Fabry Disease Treatment

[Research Material] The Global Market for Fabry Disease Treatment

Global Market for Fabry Disease Treatment: Enzyme Replacement Therapy (ERT), Chaperone Therapy, Substrate Reduction Therapy (SRT), Others, Hospitals, Clinics, Others

This research report (Global Fabry Disease Treatment Market) investigates and analyzes the current status and outlook for the global Fabry disease treatment market over the next five years. It includes information on the overview of the global Fabry disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Fabry disease treatment market include enzyme replacement therapy (ERT), chaperone therapy, substrate reduction therapy (SRT), and others, while the segments by application include hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Fabry disease treatment. It also includes the market share of major companies in Fabry disease treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Kidney Cancer & Renal Cell Carcinoma (RCC) Treatment Drugs

[Research Material] Global Market for Kidney Cancer & Renal Cell Carcinoma (RCC) Treatment Drugs

World Market for Kidney Cancer & Renal Cell Carcinoma (RCC) Treatment Drugs: Afinitor (Everolimus), Avastin (Bevacizumab), Cabomety...

This research report (Global Kidney Cancer and Renal Cell Carcinoma (RCC)) investigates and analyzes the current status and outlook for the global market of kidney cancer and renal cell carcinoma (RCC) treatment drugs over the next five years. It includes information on the overview of the global kidney cancer and renal cell carcinoma (RCC) treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Afinitor (everolimus), Avastin (bevacizumab), Cabometyx (cabozantinib), Inlyta (axitinib), Nexavar (sorafenib), Proleukin (aldesleukin), Torisel (temsirolimus), Sutent (sunitinib), and Votrient (pazopanib). The segments by application target hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] The Global Market for Stomach Cancer Treatment

[Research Material] The Global Market for Stomach Cancer Treatment

Global Market for Stomach Cancer Treatment: Programmed Cell Death Protein 1 (PD-1) Inhibitors, Human Epidermal Growth Factor Receptor (HER2) Antagonists, Vascular Endothelial ...

This research report (Global Stomach Cancer and Gastric Cancer Treatment Market) investigates and analyzes the current state of the global stomach cancer treatment market and its outlook for the next five years. It includes information on the overview of the global stomach cancer treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the stomach cancer treatment market include Programmed Cell Death Protein 1 (PD-1) inhibitors, Human Epidermal Growth Factor Receptor 2 (HER2) antagonists, Vascular Endothelial Growth Factor Receptor (VEGFR) antagonists, and others. The segments by application focus on hospitals and clinics. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for stomach cancer treatment. It also includes the market share of major companies in stomach cancer treatment, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Merkel Cell Carcinoma Treatment

[Research Material] Global Market for Merkel Cell Carcinoma Treatment

World Market for Merkel Cell Carcinoma Treatment: Chemotherapy, Immunotherapy, Combination Therapy, Others, Hospitals, Outpatient Surgery Centers, Others

This research report (Global Merkel Cell Carcinoma Treatment Market) investigates and analyzes the current state and future outlook of the global market for Merkel cell carcinoma treatment over the next five years. It includes information on the overview of the global Merkel cell carcinoma treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Merkel cell carcinoma treatment market include chemotherapy, immunotherapy, combination therapy, and others, while the segments by application include hospitals, outpatient surgical centers, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Merkel cell carcinoma treatment. It also includes the market share of major companies in the Merkel cell carcinoma treatment sector, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録
[Research Material] Global Market for Musculoskeletal (MSK) Physical Therapy

[Research Material] Global Market for Musculoskeletal (MSK) Physical Therapy

World Market for Musculoskeletal (MSK) Physiotherapy: Gels, Ointments, Creams, Sprays, Foams, Patches, Roll-ons, Musculoskeletal Disorders, Postoperative Therapy ...

This research report (Global Musculoskeletal (MSK) Physiotherapy Market) investigates and analyzes the current state and outlook for the global market of musculoskeletal (MSK) physiotherapy over the next five years. It includes information on the overview of the global musculoskeletal (MSK) physiotherapy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the musculoskeletal (MSK) physiotherapy market include gels, ointments, creams, sprays, foams, patches, and roll-ons, while the segments by application cover musculoskeletal disorders, postoperative therapy, sports medicine, post-traumatic stress, and physiotherapy. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for musculoskeletal (MSK) physiotherapy. It also includes the market share of major companies in the musculoskeletal (MSK) physiotherapy sector, product and business overviews, and sales performance.

  • Other services

ブックマークに追加いたしました

ブックマーク一覧

ブックマークを削除いたしました

ブックマーク一覧

これ以上ブックマークできません

会員登録すると、ブックマークできる件数が増えて、ラベルをつけて整理することもできます

無料会員登録

medicineに関連する検索キーワード

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.